Does PALBOCICLIB Cause Product dose omission? 442 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 442 reports of Product dose omission have been filed in association with PALBOCICLIB (Ibrance). This represents 0.5% of all adverse event reports for PALBOCICLIB.
442
Reports of Product dose omission with PALBOCICLIB
0.5%
of all PALBOCICLIB reports
20
Deaths
90
Hospitalizations
How Dangerous Is Product dose omission From PALBOCICLIB?
Of the 442 reports, 20 (4.5%) resulted in death, 90 (20.4%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 442 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which PALBOCICLIB Alternatives Have Lower Product dose omission Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID